Jade Biosciences Stock (NASDAQ:JBIO)
Previous Close
$14.15
52W Range
$8.36 - $28.00
50D Avg
$18.87
200D Avg
$18.27
Market Cap
$875.77M
Avg Vol (3M)
$894.02K
Beta
1.45
Div Yield
-
JBIO Company Profile
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.